Moderna’s mRNA RSV Vaccine Approved by the FDA

On Friday the Food and Drug Administration (FDA) approved for public use Moderna’s new mRNA respiratory syncytial virus (RSV) vaccine, mResvia, according to the company’s press release. It’s currently the only other mRNA vaccine on the market besides the ill-fated Covid injections by Moderna and Pfizer.